郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价[The role of changes in the functional activity and the amount of p-glycoprotein in drug pharmacokinetics].

期刊：Eksperimental'naia i klinicheskaia farmakologiia发表年份：2007作者：G V Ramenskaia; S L Faĭnshteĭn; D A Sychev
阅读更多 →

药效评价A cell-based Rb(+)-flux assay of the Kv1.3 potassium channel.

期刊：Assay and drug development technologies发表年份：2007作者：Sikander Gill; Rajwant Gill; David Wicks; Dong Liang
阅读更多 →

药效评价Pharmacomodulations around the 4-oxo-1,4-dihydroquinoline-3-carboxamides, a class of potent CB2-selective cannabinoid receptor ligands: consequences in receptor affinity and functionality.

期刊：Journal of medicinal chemistry发表年份：2007作者：Eric Stern; Giulio G Muccioli; Barbara Bosier; Laurie Hamtiaux; Régis Millet; Jacques H Poupaert; Jean-Pierre Hénichart; Patrick Depreux; Jean-François Goossens; Didier M Lambert
阅读更多 →

药效评价Dopamine partial agonist action of (-)OSU6162 is consistent with dopamine hyperactivity in psychosis.

期刊：European journal of pharmacology发表年份：2007作者：Philip Seeman; Hong-Chang Guan
阅读更多 →